About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials in Atlanta | 372 Studies

Clinical Trials LymphomaAtlanta

Lymphoma Clinical Trials in Atlanta

Find 372 clinical trials for lymphoma near Atlanta, Georgia. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Atlanta

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 301-320 of 372 trials

CompletedComparison of Nutritional Supplements in Preventing Weight Loss in Patients With CancerRATIONALE: Nutritional supplements may help prevent loss of appetite, weight loss, and fatigue in patients with advanced cancer.NCT00053053·Birmingham, Alabama and 249 others

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingA Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)This phase II trial studies the effect of nivolumab in combination with blinatumomab compared to blinatumomab alone in treating patients with B-cell acute lymphoblastic leukemia…NCT04546399·Birmingham, Alabama and 226 others

CompletedLisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-PILOT-017006)This is a Phase 2, open-label, multicenter study to determine the efficacy and safety of lisocabtagene maraleucel (JCAR017) in adult subjects who have relapsed from, or are…NCT03483103·Gilbert, Arizona and 58 others

CompletedPhase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line TherapyPatients with high tumor burden, low grade follicular lymphoma that has never been treated, will receive venetoclax in combination with obinutuzumab and bendamustine.NCT03113422·Atlanta, Georgia and 9 others

RecruitingExtracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell LymphomaThis phase II trial studies the effect of extracorporeal photopheresis (ECP) and mogamulizumab in treating patients with erythrodermic cutaneous T cell lymphoma (CTCL), a type of…NCT04930653·Scottsdale, Arizona and 2 others

CompletedA Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHLThis is an open-label, multi-center Phase 1/2 study of oral LOXO-305 (pirtobrutinib) in patients with CLL/SLL and NHL who have failed or are intolerant to standard of care.NCT03740529·Scottsdale, Arizona and 55 others

CompletedMORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaThis phase I trial studies the side effects and best dose of MORAb-004 in treating young patients with recurrent or refractory solid tumors or lymphoma.NCT01748721·Birmingham, Alabama and 19 others

CompletedA Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory MalignanciesAn open-label, global, multi-center study to evaluate the safety and pharmacokinetics of venetoclax monotherapy, to determine the dose limiting toxicity (DLT) and the recommended…NCT03236857·San Francisco, California and 30 others

RecruitingTesting the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or AstrocytomaThis phase I trial tests the safety, side effects, and best dose of triapine in combination with radiation therapy in treating patients with glioblastoma or astrocytoma that has…NCT06860594·Duarte, California and 42 others

CompletedNKTR-255 in Relapsed/Refractory Multiple Myeloma & Non-Hodgkin LymphomaPatients will receive intravenous (IV) NKTR-255 in 21 or 28 day treatment cycles.NCT04136756·Goodyear, Arizona and 12 others

CompletedA Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bortezomib or Are Refractory to Bortezomib. The "EMERGE" TrialTo evaluate the safety and efficacy of Lenalidomide (Revlimid (R)) in subjects with mantle cell lymphoma who have relapsed, progressed or are refractory to bortezomib.NCT00737529·Little Rock, Arkansas and 69 others

Active not recruitingObinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin LymphomaThis phase I study studies the side effects and best dose of venetoclax and lenalidomide when given together with obinutuzumab in treating patients with B-cell non-Hodgkin…NCT02992522·Atlanta, Georgia and 1 other

TerminatedStudy to Evaluate PF-04965842 in Patients With Moderate to Severe PsoriasisStudy B7451005 is a Phase 2 study which will assess the efficacy and safety of PF-04965842 in patients with moderate to severe psoriasis.NCT02201524·Birmingham, Alabama and 44 others

CompletedStudy Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)This is a multicenter, randomized, open-label, Phase IV study to assess the efficacy, tolerability, and safety of 2 initial dose levels of bexarotene capsules in participants with…NCT01007448·Birmingham, Alabama and 16 others

CompletedHIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903This is a Phase II multi-center trial single arm trial of autologous transplantation (ASCT) followed by administration of HST-NEETs for treatment of HIV associated lymphomaNCT04975698·Duarte, California and 10 others

TerminatedPhase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's DiseasePatients who have relapsed or refractory large B-cell lymphoma are being asked to take part in this study.NCT00209014·Atlanta, Georgia

CompletedMethotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS LymphomaRATIONALE: Drugs used in chemotherapy, such as methotrexate and thiotepa, work in different ways to stop cancer cells from dividing so they stop growing or die.NCT00045539·Birmingham, Alabama and 8 others

RecruitingSIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)This is a 3-part study.NCT05303519·Birmingham, Alabama and 60 others

Active not recruitingDuvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary SyndromeThis phase I trial identifies the best dose, possible benefits, and/or side effects of duvelisib in combination with nivolumab in treating patients with stage IIB-IVB mycosis…NCT04652960·Phoenix, Arizona and 16 others

Active not recruitingStudy of ONO-4685 in Patients With Relapsed or Refractory T Cell LymphomaThis study will investigate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ONO-4685 in patients with relapsed or refractory T cell LymphomaNCT05079282·Birmingham, Alabama and 20 others

PreviousPage 16 of 19Next

Other Conditions in Atlanta

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia